{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:52:45Z","timestamp":1776318765205,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":4504,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1046\/j.1469-0691.2002.00495.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T07:28:00Z","timestamp":1047367680000},"page":"534-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Problems associated with potential massive use of antimicrobial agents as prophylaxis or therapy of a bioterrorist attack"],"prefix":"10.1016","volume":"8","author":[{"given":"E.","family":"Navas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"RR-4","key":"10.1046\/j.1469-0691.2002.00495.x_bib1","first-page":"1","article-title":"Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC strategic planning workgroup","volume":"49","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib2","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1001\/jama.286.21.2711","article-title":"Large-scale quarantine following biological terrorism in the United States: scientific examination, logistic and legal limits, and possible consequences","volume":"286","author":"Barbera","year":"2001","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3201\/eid0504.990419","article-title":"Anthrax: a possible case history","volume":"5","author":"Inglesby","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(00)02769-0","article-title":"Public-health preparedness for biological terrorism in the USA","volume":"356","author":"Khan","year":"2000","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib5","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.281.18.1735","article-title":"Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Inglesby","year":"1999","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib6","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1001\/jama.285.21.2763","article-title":"Tularemia as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"285","author":"Dennis","year":"2001","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib7","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib8","first-page":"889","article-title":"Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib9","first-page":"1008","article-title":"Investigation of bioterrorism-related anthrax, 2001","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib10","series-title":"Principles and practice of infectious diseases","first-page":"2393","article-title":"Francisella tularensis (tularemia)","author":"Cross","year":"2000"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/41.4.461","article-title":"The efficacy of ciprofloxacin and doxycycline against experimental tularaemia","volume":"41","author":"Russell","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s100960050219","article-title":"Microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections","volume":"18","author":"Smego","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"RR-14","key":"10.1046\/j.1469-0691.2002.00495.x_bib13","first-page":"1","article-title":"Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"45","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jac\/41.2.301","article-title":"Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection","volume":"41","author":"Russell","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/AAC.42.3.675","article-title":"Antibiotic treatment of experimental pneumonic plague in mice","volume":"42","author":"Byrne","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib16","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1001\/jama.284.13.1648","article-title":"Safety precautions to limit exposure from plague-infected patients","volume":"284","author":"Nolte","year":"2000","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3201\/eid0701.010106","article-title":"Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis","volume":"7","author":"Guiyoule","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199709043371004","article-title":"Multi-drug resistance in Yersinia pestis mediated by a transferable plasmid","volume":"337","author":"Galimand","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib19","series-title":"Health aspects of chemical and biological weapons","year":"1970"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib20","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1073\/pnas.90.6.2291","article-title":"Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979","volume":"90","author":"Abramova","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib21","first-page":"973","article-title":"Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/scientificamerican0398-46","article-title":"The challenge of antibiotic resistance","volume":"278","author":"Levy","year":"1998","journal-title":"Sci Am"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM200110183451610","article-title":"Antimicrobial use in animal feed;time to stop","volume":"345","author":"Gorbach","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/AAC.40.2.503","article-title":"Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis","volume":"40","author":"Carratala","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib25","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1086\/315132","article-title":"Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era","volume":"180","author":"Martin","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/jac\/41.3.420","article-title":"Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland","volume":"41","author":"Goldsmith","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib28","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJM199911113412013","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae","volume":"341","author":"Li\u00f1ares","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib29","first-page":"1547","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae","volume":"341","author":"Peterson","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib30","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1128\/AAC.44.12.3481-3482.2000","article-title":"Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in Spain","volume":"44","author":"Garcia-Rey","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4065\/74.7.727","article-title":"The tetracyclines","volume":"74","author":"Smilack","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archinte.161.1.15","article-title":"Anaphylaxis in the United States: an investigation into its epidemiology","volume":"161","author":"Neugut","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib33","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0149-2918(00)80053-3","article-title":"The safety profile of the fluoroquinolones","volume":"22","author":"Bertino","year":"2000","journal-title":"Clin Ther"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1177\/106002809202600905","article-title":"Hypersensitivity and anaphylactoid reactions to ciprofloxacin","volume":"26","author":"Deamer","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib35","first-page":"535","article-title":"Safety of the new quinolones in pregnancy","volume":"84","author":"Berkovitch","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib36","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/AAC.42.6.1336","article-title":"Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study","volume":"42","author":"Loebstein","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2002.00495.x_bib37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0029-7844(97)00005-7","article-title":"Teratogenic study of doxycycline","volume":"89","author":"Czeizel","year":"1997","journal-title":"Obstet Gynecol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14626434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14626434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:15:57Z","timestamp":1761117357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14626434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S1198743X14626434"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2002.00495.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Problems associated with potential massive use of antimicrobial agents as prophylaxis or therapy of a bioterrorist attack","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1469-0691.2002.00495.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}